Article Text

Download PDFPDF
Prediction rule
A clinical risk score to predict the incidence of postpartum venous thromboembolism
  1. Marc Blondon1,
  2. Justine Hugon-Rodin2
  1. 1Division of Angiology and Hemostasis, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland
  2. 2Unit for Reproductive Medicine and Gynaecological Endocrinology, Department of Gynaecology and Obstetrics, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland
  1. Correspondence to: Dr Marc Blondon, Division of Angiology and Hemostasis, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland; marc.blondon{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Commentary on: OpenUrlAbstract/FREE Full Text


Around 1 in 1000 postpartum women suffers from venous thromboembolism (VTE).1 The occurrence of deep vein thromboses (DVT), often found in proximal veins, may affect long-term quality of life,2 and pulmonary embolisms (PE) are a leading cause of direct maternal death in this very healthy population. Given the overall low absolute risk of VTE, as well as the cost of thromboprophylaxis and its possible side-effects, the use of prophylactic heparin is unreasonable if given universally, but should be tailored to individual risks. The aim of this study was to generate a validated risk-assessment model or prediction tool to estimate the absolute risk of postpartum VTE in individual women.


Using two population-based …

View Full Text


  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.